Overview SPC3649 Multiple Dose Study in Healthy Volunteers Status: Completed Trial end date: 2010-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the safety and tolerability of SPC3649 given in multiple doses to healthy volunteers. Phase: Phase 1 Details Lead Sponsor: Santaris Pharma A/S